Biliary Atresia Animal Models: Is the Needle in a Haystack?

Area of Science:

• Hepatology
• Pediatric Gastroenterology
• Toxicology

Background:

• Biliary atresia (BA) is a progressive, inflammatory liver disease impacting infants, with significant patient and healthcare burdens.
• It is a leading cause of pediatric liver transplantation, highlighting the urgent need for effective treatments.
• The heterogeneous etiology and complex pathophysiology of BA necessitate robust research models.

Purpose of the Study:

• To review and compile existing animal models for studying biliary atresia.
• To identify gaps and suggest future directions for developing better BA research models.
• To facilitate the identification of novel therapeutic targets for BA.

Main Methods:

• Comprehensive literature search for published animal models of biliary atresia.
• Analysis of model characteristics, including induction methods, disease manifestation, and relevance to human BA.
• Synthesis of findings to highlight strengths, limitations, and future research needs.

Main Results:

• Various animal models exist, but none perfectly replicate human BA, posing a challenge for research.
• Key areas for model improvement include understanding noxa-related hepatotoxicity mechanisms and incorporating genetic factors.
• The review identifies a need for data sharing platforms and advanced techniques like gene expression analysis.

Conclusions:

• Developing highly functional animal models for BA is crucial but challenging.
• Further research into transport and cell membrane studies, data sharing platforms, and gene expression analysis is recommended.
• A combinatorial approach to model development holds promise for advancing BA research and treatment strategies.